STUDIOLSD — Studio LSD Income Statement
0.000.00%
- IN₹1.01bn
- IN₹961.06m
- IN₹1.04bn
- 81
- 66
- 33
- 67
Annual income statement for Studio LSD, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 146 | 467 | 1,025 | 1,045 |
| Cost of Revenue | ||||
| Gross Profit | 53.9 | 135 | 358 | 400 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Total Operating Expenses | 137 | 430 | 878 | 892 |
| Operating Profit | 9.41 | 37 | 146 | 153 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 9.03 | 36.4 | 147 | 158 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 9.1 | 27.9 | 109 | 117 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 9.1 | 27.9 | 109 | 117 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 9.1 | 27.9 | 109 | 117 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.175 | 0.539 | 2.1 | 2.25 |